opioid sparing onco-anesthesia for paediatric patients.

Phase 3

Recruiting

• Conditions: Cancer; Paediatrics; Anaesthesia

• Registration Number: PACTR202008462414719
• Lead Sponsor: Dr Mona Raafat Elghamry

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-08-07
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 88

Inclusion Criteria

eighty eight child aged 2-10 years,
ASA physical status I and II,
scheduled for brief intervention related to cancer (e.g. intrathecal delivery of chemotherapy, bone marrow aspiration)

Exclusion Criteria

parents' refusal,
procedures > 30 min,
complicated interventions,
impaired renal or hepatic function,
allergy or contraindication to any of studied drugs

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
total fentanyl consumption

Secondary Outcome Measures

Name	Time	Method
Hemodynamic parameters (HR and MAP) ;Frequency of movement;Recovery time ;Pain score;Length of PACU stay;Any adverse effects e.g. PONV, postoperative agitation